These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 27696293

  • 1. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
    Pramanik KK, Singh AK, Alam M, Kashyap T, Mishra P, Panda AK, Dey RK, Rana A, Nagini S, Mishra R.
    Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
    [Abstract] [Full Text] [Related]

  • 2. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
    Pramanik KK, Nagini S, Singh AK, Mishra P, Kashyap T, Nath N, Alam M, Rana A, Mishra R.
    Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.
    Wang L, Ge J, Ma T, Zheng Y, Lv S, Li Y, Liu S.
    Tumour Biol; 2015 Dec; 36(12):9511-6. PubMed ID: 26130413
    [Abstract] [Full Text] [Related]

  • 6. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.
    Long NK, Kato K, Yamashita T, Makita H, Toida M, Hatakeyama D, Hara A, Mori H, Shibata T.
    Oral Oncol; 2008 Nov; 44(11):1052-8. PubMed ID: 18485791
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells.
    Kato K, Long NK, Makita H, Toida M, Yamashita T, Hatakeyama D, Hara A, Mori H, Shibata T.
    Br J Cancer; 2008 Aug 19; 99(4):647-54. PubMed ID: 18665171
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
    Liu X, Wang W, Chen J, Chen C, Zhou J, Cao L.
    ORL J Otorhinolaryngol Relat Spec; 2012 Aug 19; 74(1):16-21. PubMed ID: 22178867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
    Chang HC, Cho CY, Hung WC.
    Cancer Sci; 2007 Feb 19; 98(2):169-73. PubMed ID: 17233834
    [Abstract] [Full Text] [Related]

  • 13. Prognostic role of RECK in pathological outcome-dependent buccal mucosa squamous cell carcinoma.
    Chen HC, Tseng YK, Shu CW, Fu TY, Liou HH, Huang CH, Chen CC, Wang JS, Wu PC, Ger LP, Hung WC, Liu PF.
    Oral Dis; 2020 Jan 19; 26(1):62-71. PubMed ID: 31618798
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
    Lee KJ, Lee KY, Lee YM.
    Biochim Biophys Acta; 2010 May 19; 1803(5):608-16. PubMed ID: 20080132
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of 5-aza-2'deoxycytidine on RECK gene expression and tumor invasion in salivary adenoid cystic carcinoma.
    Zhou XQ, Huang SY, Zhang DS, Zhang SZ, Li WG, Chen ZW, Wu HW.
    Braz J Med Biol Res; 2015 Mar 19; 48(3):254-60. PubMed ID: 25517920
    [Abstract] [Full Text] [Related]

  • 17. Epigallocatechin‑3‑gallate inhibits the invasion of salivary adenoid cystic carcinoma cells by reversing the hypermethylation status of the RECK gene.
    Zhou XQ, Xu XN, Li L, Ma JJ, Zhen EM, Han CB.
    Mol Med Rep; 2015 Oct 19; 12(4):6031-6. PubMed ID: 26299812
    [Abstract] [Full Text] [Related]

  • 18. The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.
    Alam M, Kashyap T, Pramanik KK, Singh AK, Nagini S, Mishra R.
    Clin Oral Investig; 2017 Dec 19; 21(9):2721-2731. PubMed ID: 28233171
    [Abstract] [Full Text] [Related]

  • 19. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y, Liang H, Chen W, Zhang H, Wang N, Wang F, Zhang S, Liu Y, Zhao C, Yan X, Zhang J, Zhang CY, Gu H, Zen K, Chen X.
    RNA Biol; 2015 Dec 19; 12(3):276-89. PubMed ID: 25826661
    [Abstract] [Full Text] [Related]

  • 20. Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer.
    Jung HM, Phillips BL, Patel RS, Cohen DM, Jakymiw A, Kong WW, Cheng JQ, Chan EK.
    J Biol Chem; 2012 Aug 24; 287(35):29261-72. PubMed ID: 22761427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.